Computer-Aided Drug Discovery Market to Reach $7.5 Bn, Globally, by 2030 at 11.48% CAGR: Allied Market Research

6 min


Rise in cases of chronic and unknown diseases and rapid drug development drive the growth of the global computer-aided drug discovery market.

PORTLAND, Ore., July 13, 2022 /PRNewswire/ — Allied Market Research published a report, titled, Computer-Aided Drug Discovery Market by Type (Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches), by Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others), by End User (Pharmaceutical Companies, Biotechnology Companies, Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2021-2030.’ According to the report published by Allied Market Research, the global computer-aided drug discovery market was estimated at $2.9 billion in 2021 and is expected to hit $7.5 billion by 2030, registering a CAGR of 11.48% from 2022 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Allied Market Research Logo

Download Report (180 Pages PDF with Insights, Charts, Tables, Figures):

Prime determinants of growth-

Rise in cases of chronic and unknown diseases and rapid drug development drive the growth of the global computer-aided drug discovery market. On the other hand, shortage of skilled labor to operate computer-aided drug discovery solutions impedes the growth to some extent. However, several growth prospects in the developed and developing economies have been beneficial for the market growth.

Covid-19 scenario-

Despite the fact that the Covid-19 pandemic had a devastating effect on several industries, the computer-aided drug discovery market was driven positively throughout the global health crisis.

Increased R&D activities among scientists, researchers, biotechnological and biopharmaceutical companies to limit the spread disease impacted the market positively.

Specific Requirement on COVID-19? Ask Our Industry Expert:

The oncology segment to retain the lion’s share-

On the basis of therapeutic area, the oncology segment held the major share in 2021, garnering nearly one-fourth of the global computer-aided drug discovery market. The same segment is also projected to cite the fastest CAGR of 12.29% throughout the forecast period. Rise in R&D activities to discover novel drugs drives the growth of the segment.

The pharmaceutical companies segment to dominate by 2030-

By end-user, the pharmaceutical companies segment contributed to the lion’s share in 2021, holding more than two-fifths of the global computer-aided drug discovery market. The biotechnology companies’ segment, on the other hand, is expected to manifest the fastest CAGR of 11.97% from 2022 to 2030. Increase in R&D sending to develop biologics for treating several diseases propels the segment growth.

North America exhibited the fastest CAGR throughout the forecast period-

By region, the market across North America dominated in 2021, garnering more than one-third of the global computer-aided drug discovery market. The Asia-Pacific region, simultaneously, is anticipated to cite the fastest CAGR of 12.84% throughout the forecast period. Increasing number of biotechnology companies and R&D expenditure is the major factor are the major factors driving the market growth.

Key players in the industry-

  • Schrödinger, Inc.
  • Bayer AG
  • Aragen Life Sciences Pvt. Ltd.
  • Aris Pharmaceuticals, Inc.
  • AstraZeneca
  • Albany Molecular Research Inc. (AMRI)
  • Bioduro-Sundia
  • Charles River Laboratories

Key Benefits for Stakeholders

The study provides an in-depth analysis of the computer-aided drug discovery market size along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers computer-aided drug discovery market analysis from 2021 to 2031, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global computer-aided drug discovery market growth.

We also Offers Regional and Country Reports-

North America Computer-Aided Drug Discovery Market
Japan Computer-Aided Drug Discovery Market
South Korea Computer-Aided Drug Discovery Market
Singapore Computer-Aided Drug Discovery Market
Australia Computer-Aided Drug Discovery Market
Europe Computer-Aided Drug Discovery Market

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial:

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):

Surgical Equipment Market Overview:

The global surgical equipment market size valued at $31,722.30 million in 2019 and is estimated to reach $44,448.58 million by 2027, at a CAGR of 6.3% during the forecast period.

Orthodontics Market Overview:

The global orthodontics market size was valued at $2,767.4 million in 2020, and is projected to reach $7,637.8 million by 2030, registering a CAGR of 10.7% from 2021 to 2030.

Digital Therapeutics (DTx) Market Overview:

The global digital therapeutics market was valued at $3,537.29 million in 2020, and is projected to reach $23,569.38 million by 2030, registering a CAGR of 20.6% from 2021 to 2030.

Telemedicine Market Overview:

The global telemedicine market size was valued at $40,205.68 million in 2020, and is estimated to reach $431,823.81 million by 2030, growing at a CAGR of 25.90% from 2021 to 2030.

Medical Spa Market Overview:

The global medical spa market size was valued at $12,438 million in 2020, and is estimated to reach $29,542.33 million by 2030, growing at a CAGR of 9% from 2021 to 2030.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Follow Us on LinkedIn:


Like it? Share with your friends!